Camlin Fine Sciences vs Archean Chemical Industries: Share Price, Comparison and Key Differences

Camlin Fine Sciences vs Archean Chemical Industries is a comparison specialty chemicals investors look up when evaluating two listed Indian specialty chemical companies with unique product niches. Camlin Fine Sciences, a Mumbai-based company, manufactures antioxidants and specialty chemicals – food antioxidants (BHA, BHT, TBHQ for edible oils and fats), feed antioxidants and performance chemicals for plastics, rubber and lubricants. Archean Chemical Industries, a Bengaluru-based company, is India's largest bromine producer and salt manufacturer – extracting bromine and industrial salt from sea brine and manufacturing downstream bromine chemicals for pharma, flame retardants and oilfield chemicals. Both Camlin Fine Sciences vs Archean Chemical are specialty chemical niche players.

This Camlin Fine Sciences vs Archean Chemical Industries article covers reach and market position, key products, latest declared results and stock valuation. All data is sourced from Groww and public company filings.

Reach and Market Position

In this Camlin Fine Sciences vs Archean Chemical Industries comparison, Camlin Fine Sciences sells food antioxidants, feed antioxidants and performance chemicals to global FMCG, edible oil and specialty polymer companies. Market capitalisation is Rs 2,429 Cr.

Click Here – Get Free Investment Predictions

Archean Chemical manufactures bromine, sea salt and downstream bromine compounds for pharma, flame retardant and oilfield chemical applications. Market capitalisation is Rs 6,254 Cr.

Key Products and Business Mix

For the Camlin Fine Sciences vs Archean Chemical Industries product breakdown, Camlin Fine Sciences: Camlin Fine earns from food antioxidants (BHA, TBHQ), feed antioxidants and performance chemicals. EPS is Rs 1.23 (near-zero!). PE is 102.80x, ROE 1.18 percent (very thin), D/E 0.69. Camlin has near-zero earnings.

Archean Chemical Industries: Archean earns from bromine, sea salt and specialty bromine chemicals. EPS is Rs 7.75. PE is 65.37x, ROE 5.52 percent, D/E 0.24.

Latest Results and Financial Data

On the Camlin Fine Sciences vs Archean Chemical Industries results front: Camlin Fine Sciences has a market cap of Rs 2,429 Cr but near-zero earnings (PE 102.80x, ROE 1.18 percent). Camlin has thin profitability after a challenging phase in its antioxidant business.

Archean Chemical Industries has a market cap of Rs 6,254 Cr and PE of 65.37x. ROE is 5.52 percent. Archean is 2.6 times larger than Camlin and more profitable, but both have thin ROE.

Compare Camlin Fine Sciences and Archean Chemical Industries Fundamentals on the Univest Screener

Stock Performance and Valuation

Investors tracking the Camlin Fine Sciences vs Archean Chemical Industries comparison should verify current prices on NSE or BSE before trading. The Camlin Fine Sciences vs Archean Chemical Industries stock data below reflects the latest available figures from Groww and public company filings.

Camlin Fine Sciences vs Archean Chemical Industries at current valuations: Camlin trades at Rs 2,429 Cr market cap, PE 102.80x (near-zero earnings). Archean trades at Rs 6,254 Cr market cap, PE 65.37x, ROE 5.52 percent. Both have thin earnings and expensive PE ratios. Archean is larger and relatively more profitable than Camlin.

Camlin Fine Sciences vs Archean Chemical Industries: Quick Comparison Table

The comparison table below summarises the key metrics side by side.

Parameter	Camlin Fine Sciences	Archean Chemical Industries
Sector	Food + feed antioxidants: BHA, TBHQ, BHT + performance chemicals	Bromine + sea salt + bromine compounds: pharma, flame retardant, oilfield
Market Cap	Rs 2,429 Cr	Rs 6,254 Cr
P/E Ratio	102.80x (near-zero earnings!)	65.37x
ROE	1.18% (very thin)	5.52% (thin)
Profitability	Near-zero earnings	Thin but positive
Debt to Equity	0.69	0.24
Products	BHA, BHT, TBHQ (food antioxidants) + polymer antioxidants	Bromine, industrial sea salt, specialty bromine chemicals

Conclusion

The Camlin Fine Sciences vs Archean Chemical Industries comparison above covers reach, products, results and valuation. Camlin Fine Sciences vs Archean Chemical covers antioxidant specialty chemicals versus bromine and marine chemicals. Both are niche specialty chemical companies with thin current ROE. Camlin has near-zero earnings. Archean is profitable but with thin margins. Camlin vs Archean investors must note that both have very thin current profitability and high PE ratios. Consult a SEBI-registered advisor for personalised guidance.

Download the Univest iOS App or Univest Android App to track Camlin Fine Sciences and Archean Chemical Industries live price and get daily stock recommendations.

Frequently Asked Questions

What does Camlin Fine Sciences make?

Ans. Camlin Fine Sciences manufactures food antioxidants (BHA, BHT, TBHQ – used to prevent rancidity in edible oils, fats and food products), feed antioxidants for animal nutrition and performance chemicals for plastics and rubber.

What does Archean Chemical produce?

Ans. Archean Chemical Industries extracts bromine from sea brine in Gujarat and produces industrial sea salt, plus downstream bromine chemicals used in pharma synthesis, flame retardants for electronics and oilfield drilling chemicals.

What is an antioxidant in food?

Ans. Food antioxidants (like BHA, BHT, TBHQ) are additives that prevent fats and oils from oxidizing and becoming rancid. They extend shelf life of edible oils, snacks, margarine and other fat-containing foods.

What is bromine used for?

Ans. Bromine is a chemical element used in flame retardants (for electronics and textiles), pharmaceuticals (as synthesis building blocks), water treatment, oilfield chemicals and agricultural chemicals.

Are Camlin and Archean in Nifty 50?

Ans. Neither is in Nifty 50. Both are tracked in smaller indices.

Which is larger?

Ans. Archean Chemical Industries at Rs 6,254 Cr is approximately 2.6 times larger than Camlin Fine Sciences at Rs 2,429 Cr.

Is Camlin profitable?

Ans. Camlin Fine Sciences has near-zero earnings (PE 102.80x, ROE 1.18%). Investors should verify the latest quarterly financials from exchange filings before any investment decision.